Results for &quot;&quot;Receptors, Neurokinin-1&quot;&quot;[mesh_terms]

Detection of the full-length transcript variant for neurokinin-1 receptor in human whole blood associated with enhanced reinforcement of clot by substance-P.

Toshiharu Azma, Yuki Sugimoto, Hiroyuki Kinoshita, Taishin Ito, Masanori Tsukamoto, Hiroshi Hoshijima, Masakazu Nakao, Hirosato Kikuchi

Journal of thrombosis and thrombolysis 2012;33(4):329-37

Medicinal herbs in treating chemotherapy-induced nausea and vomiting: A review.

Reza Rajabalizadeh, Mahboobeh Ghasemzadeh Rahbardar, Hossein Hosseinzadeh

Phytotherapy research : PTR 2022;36(10):3691-3708

The involvement of the substance P/neurokinin 1 receptor system in viral infection: focus on the gp120 fusion protein and homologous dipeptide domains.

M Muñoz, M Krämer, R Coveñas

Acta virologica 2019;63(3):253-260

Changes in the distribution and connectivity of interneurons in the epileptic human dentate gyrus.

Z Maglóczky, L Wittner, Z Borhegyi, P Halász, J Vajda, S Czirják, T F Freund

Neuroscience 2000;96(1):7-25

Neurokinin-1 receptor desensitization to consecutive microdialysis infusions of substance P in human skin.

Christopher T Minson, Nathan J Tublitz, Brett J Wong

The Journal of physiology 2006;568(Pt 3):1047-56

Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant.

Mats Bergström, Richard J Hargreaves, H Donald Burns, Michael R Goldberg, David Sciberras, Scott A Reines, Kevin J Petty, Mattias Ogren, Gunnar Antoni, Bengt Långström, Olli Eskola, Mika Scheinin, Olof Solin, Anup K Majumdar, Marvin L Constanzer, Wendy P Battisti, Thomas E Bradstreet, Cynthia Gargano, Jarmo Hietala

Biological psychiatry 2004;55(10):1007-12

Depression, Nutritional Status, and Substance P/NK-1R Biomarkers in Dysmenorrhea: A Randomized Crossover Trial.

Riffat Mehboob, Imran Shahid, Akash John, Shahzad Ahmad, Zeeshan Mehboob, Shadi Ahmed Alahmadi, Hisham Nasief, Ahmad Alwazzan, Khalid A Khadawardi

Depression and anxiety 2026;2026():9538518

The neuropeptide substance P regulates aldosterone secretion in human adrenals.

Julien Wils, Céline Duparc, Anne-Françoise Cailleux, Antoine-Guy Lopez, Caroline Guiheneuf, Isabelle Boutelet, Hadrien-Gaël Boyer, Christophe Dubessy, Saloua Cherifi, Bruno Cauliez, Françoise Gobet, Guillaume Defortescu, Jean-François Ménard, Estelle Louiset, Hervé Lefebvre

Nature communications 2020;11(1):2673

Tachykinin activation of human monocytes from patients with interstitial lung disease, healthy smokers or healthy volunteers.

S Brunelleschi, R Nicali, L Lavagno, I Viano, E Pozzi, L Gagliardi, P Ghio, C Albera

Neuropeptides 2000;34(1):45-50

Neurokinin-1 receptor desensitization attenuates cutaneous active vasodilatation in humans.

Brett J Wong, Christopher T Minson

The Journal of physiology 2007;577(Pt 3):1043-51

Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant.

Deepti Jacob, Irene Busciglio, Duane Burton, Houssam Halawi, Ibironke Oduyebo, Deborah Rhoten, Michael Ryks, W Scott Harmsen, Michael Camilleri

American journal of physiology. Gastrointestinal and liver physiology 2017;313(5):G505-G510

Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults.

Pablo Tebas, Sergei Spitsin, Jeffrey S Barrett, Florin Tuluc, Okan Elci, James J Korelitz, Wayne Wagner, Angela Winters, Deborah Kim, Renae Catalano, Dwight L Evans, Steven D Douglas

AIDS (London, England) 2016;29(8):931-9

Substance P-induced cyclooxygenase-2 expression in human umbilical vein endothelial cells.

Margherita Gallicchio, Arianna Carolina Rosa, Elisa Benetti, Massimo Collino, Chiara Dianzani, Roberto Fantozzi

British journal of pharmacology 2006;147(6):681-9